<DOC>
	<DOCNO>NCT02794493</DOCNO>
	<brief_summary>RATIONALE : Hand foot syndrome may treat reduce soak Traditional Chinese Medicine Formula LC09 patient receive capecitabine colorectal and/or breast cancer . PURPOSE : This randomized phase III trial study soak Traditional Chinese Medicine Formula LC09 see well work compare placebos prevent hand-foot syndrome patient receive capecitabine colorectal breast cancer .</brief_summary>
	<brief_title>Treatment Hand Foot Syndrome With Traditional Chinese Medicine Formula LC09 Patients Who Are Receiving Capecitabine Colorectal and/or Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : OBJECTIVES : Determine whether Traditional Chinese Medicine Formula LC09 treat reduce severity capecitabine-caused hand foot syndrome . Evaluate potential toxicity Traditional Chinese Medicine Formula LC09 . OUTLINE : This multicenter , randomize , double-blind , placebo-controlled study . Patients randomize 2 treatment arm . Arm I : Patients receive Traditional Chinese Medicine Formula LC09 soak affected hand foot 20 min twice daily . Arm II : Patients receive placebo soaking affect hand foot 20 min twice daily .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Hand-Foot Syndrome</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>Subjects must meet follow criterion eligible study : 1 . Histologically confirm colorectal cancer breast cancer , colorecta cancer advance undergoing adjuvant therapy radical resection breast cancer stage recurrence metastasis ; 2 . Level 1 HFS receive capecitabine part routine standard care ; 3 . Plan receive capecitabine part routine 2 week ; 4 . ECOG performance status 02 ; 5 . Life expectancy great equal 3 month ; 6 . No serious heart , liver , kidney important viscera dysfunction , define : absolute neutrophil count great equal 1.5 x 10 ( 9 ) /L platelet count great equal 100 x 10 ( 9 ) /L hemoglobin great equal 9.0 g/dL total bilirubin less equal 1.5 time ULN AST/SGOT ALT/SGPT less equal 2.5 time ULN ( less equal 5 time ULN liver function abnormality due underlying malignancy ) creatinine less equal 1.5 time ULN creatinine clearance great equal 60 ml/min ( CockcroftGault ) 7 . Ability cooperate HFS grade evaluation , understand willingness sign write informed consent document . Subjects meet follow criterion ineligible study entry : 1 . Concurrent level 1 peripheral neuropathy ( diabetic neuropathy chemotherapy induce peripheral neuropathy ) ; 2 . Other acute chronic inflammatory condition infection hand foot would complicate safety , application topical cream , study endpoint ; 3 . Currently take treatment PPE ( include topical urea cream , pyridoxine , celecoxib , compound matrine injection deproteinized calf blood extractive injection ) ; 4 . History severe uncontrolled organic disease infection , heart , pulmonary renal failure cause termination chemotherapy ; 5 . Pregnant ( positive pregnancy test ) nursing woman ; 6 . Participating clinical trial currently within 4 week .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>